Literature DB >> 10068592

Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis.

P B Wyrick1, S T Knight, T R Paul, R G Rank, C S Barbier.   

Abstract

An in vitro coculture model system was used to explore conditions that trigger neutrophil chemotaxis to Chlamydia trachomatis infected human epithelial cells (HEC-1B). Polarized HEC-1B monolayers growing on extracellular matrix (ECM) were infected with C. trachomatis serovar E. By 36 h, coincident with the secretion of chlamydial lipopolysaccharide and major outer membrane protein to the surfaces of infected cells, human polymorphonuclear neutrophils (PMNL) loaded with azithromycin migrated through the ECM and infiltrated the HEC-1B monolayer. Bioreactive azithromycin was delivered by the chemotactic PMNL to infected epithelial cells in concentrations sufficient to kill intracellular chlamydiae. However, residual chlamydial envelopes persisted for 4 weeks, and PMNL chemotaxis was triggered to epithelial cells containing residual envelopes. Infected endometrial cells demonstrated up-regulation of ENA-78 and GCP-2 chemokine mRNA. Thus, despite appropriate antimicrobial therapy, residual chlamydial envelope antigens may persist in infected tissues of culture-negative women and provide one source for sustained inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068592     DOI: 10.1086/314676

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.

Authors:  B K Coombes; J B Mahony
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.

Authors:  W J Brown; Y A W Skeiky; P Probst; D D Rockey
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Authors:  Paul F Riska; Andrei Kutlin; Patrick Ajiboye; Arnold Cua; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo.

Authors:  R A Hawkins; R G Rank; K A Kelly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.

Authors:  Raymond M Johnson; Micah S Kerr
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

7.  Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice.

Authors:  K H Ramsey; I M Sigar; J H Schripsema; N Shaba; K P Cohoon
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.

Authors:  Matthew J Burton; Athumani Ramadhani; Helen A Weiss; Victor Hu; Patrick Massae; Sarah E Burr; Wahida Shangali; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

9.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.

Authors:  Aldona Dlugosz; Hans Törnblom; Ghazaleh Mohammadian; Gareth Morgan; Béla Veress; Benjamin Edvinsson; Gunnar Sandström; Greger Lindberg
Journal:  BMC Gastroenterol       Date:  2010-02-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.